Applied Genetic Technologies (AGTC) Reports Q2 Loss of $0.29/Share

Applied Genetic Technologies (NASDAQ: AGTC) reported Q2 EPS of ($0.29), versus $0.10 reported last year. Revenue for the quarter came in at $4.85 million, versus $10.9 million reported last year.

For earnings history and earnings-related data on Applied Genetic Technologies (AGTC) click here.

You May Also Be Interested In

• Gilead Sciences (GILD) Misses Q1 EPS by 288c
• Minerals Technologies (MTX) Tops Q1 EPS by 16c
• Edwards Lifesciences (EW) Tops Q1 EPS by 2c; offers guidance